282 results on '"Wekerle, T"'
Search Results
2. Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study
3. Regulatory T Cells Promote Natural Killer Cell Education in Mixed Chimeras
4. The Immunosuppressive Effect of CTLA4 Immunoglobulin Is Dependent on Regulatory T Cells at Low But Not High Doses
5. Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study
6. Rapamycin and CTLA4Ig Synergize to Induce Stable Mixed Chimerism Without the Need for CD40 Blockade
7. Donor CD4 T Cells Trigger Costimulation Blockade-Resistant Donor Bone Marrow Rejection Through Bystander Activation Requiring IL-6
8. Belatacept-Based Immunosuppression in De Novo Liver Transplant Recipients: 1-Year Experience From a Phase II Randomized Study
9. Bcl-2 Inhibition to Overcome Memory Cell Barriers in Transplantation
10. T Cell Subsets Predicting Belatacept‐Resistant Rejection: Finding the Root Where the Trouble Starts
11. Treg-Therapy Allows Mixed Chimerism and Transplantation Tolerance Without Cytoreductive Conditioning
12. Anti-OX40L alone or in combination with anti-CD40L and CTLA4Ig does not inhibit the humoral and cellular response to a major grass pollen allergen
13. Long-Term Survival Outcomes in Belatacept-Treated vs. Cyclosporine-Treated Patients: Final Results From BENEFIT-EXT: Abstract# P-45
14. Murine Mobilized Peripheral Blood Stem Cells Have a Lower Capacity than Bone Marrow to Induce Mixed Chimerism and Tolerance
15. T-Regulatory Cells—What Relationship With Immunosuppressive Agents?
16. Short-Term Effects of High-Dose Zoledronic Acid Treatment on Bone Mineralization Density Distribution After Orthotopic Liver Transplantation
17. Prophylactic Bisphosphonate Treatment Prevents Bone Fractures After Liver Transplantation
18. Persistent molecular microchimerism induces long-term tolerance towards a clinically relevant respiratory allergen
19. Recipient Age Facilitates Bone Marrow Transplantation-Based Tolerance Induction.: Abstract# 1120: Poster Board #-Session: P285-II
20. No Evidence for Recipient-Derived Hepatocytes in Serial Biopsies of Sex-Mismatched Liver Transplants.: Abstract# 922 Poster Board #-Session: P87-II
21. Donor-Derived Passenger Leukocytes Are Critical for the Accelerated Rejection of Cardiac Allografts from Old Donors.: Abstract# 632: Poster Board#-Session: P100-I
22. Ex Vivo Recipient Expanded Regulatory T-Cells Promote Prolonged Mixed Hematopoietic Chimerism and Renal Allograft Tolerance in a Non-Myeloablative Non-Human Primate Bone Marrow Transplantation Model.: Abstract# 504
23. (114) Prophylactic Use of Extracorporeal Photopheresis (ecp) - A Prospective Randomized Single Center Trial
24. Co-stimulation blockade to modulate allogeneic T-cell responses: P850
25. Indoleamine 2,3-dioxygenase (IDO) and Treg support are critical for CTLA4Ig mediated tolerance induction to solid organ allografts: 055
26. Rejection of donor bone marrow triggered by donor T cells is associated with an increase in IL-17A, IFN-γ and IL-6: 010
27. Role of CD40-CD154 pathway in the rejection of concordant and discordant xenogeneic islets
28. Phylogenetic disparity influences the predominance of direct over indirect pathway of antigen presentation in islet xenotransplantation
29. Pulmonale Thrombendarterektomie: Die Therapie der chronisch thromboembolischen pulmonalen Hypertension— Initiale chirurgische Erfahrung
30. The advantage of allocating kidneys from old cadaveric donors to old recipients: a single-center experience
31. Operative Therapie tracheointestinaler Fisteln
32. Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor
33. Short-Time Effect of Alemtuzumab Induction Therapy on B- and T-cell Subsets After Lung Transplantation
34. Comprehensive Immunophenotypic Monitoring in a Prospective Randomized Controlled Trial of Prophylactic Use of Extracorporeal Photopheresis (ECP) in Lung Transplantation
35. No augmentation of indoleamine 2,3‐dioxygenase (IDO) activity through belatacept treatment in liver transplant recipients.
36. Murine models of transplantation tolerance through mixed chimerism: advances and roadblocks.
37. Role of peripheral clonal deletion in tolerance induction with bone marrow transplantation and costimulatory blockade
38. Treg Treatment Prevents Heart Allograft Vasculopathy in a Murine Mixed Chimerism Model
39. Influence of an anti-CD25 mAB on tolerance induction through BMT with costimulation blockade
40. Impact of human leukocyte antigen (HLA) matching on graft survival after lung transplantation
41. The effects of rapamycin and cyclosporin a on tolerance induction through bone marrow transplantation with costimulation blockade
42. AN IRRADIATION-FREE PROTOCOL FOR MIXED CHIMERISM AND TOLERANCE THROUGH TREG-THERAPY.
43. MACROPHAGE DEPLETION PROLONGS DISCORDANT BUT NOT CONCORDANT ISLET XENOGRAFT SURVIVAL.
44. ANTI-CD25 MAB, ANTI-IL2 MAB AND IL2 BLOCK TOLERANCE INDUCTION THROUGH ANTI-CD154 MAB AND RAPAMYCIN IN XENOGENEIC ISLET TRANSPLANTATION.
45. CO-STIMULATION BLOCKADE WITH LEA29Y IN A CALCINEURIN INHIBITOR FREE MAINTENANCE REGIMEN IN RENAL TRANSPLANT: 6-MONTH EFFICACY AND SAFETY.
46. SHORT-COURSE IMMUNOSUPPRESSION FACILITATES CHIMERISM AND TOLERANCE IN A NON-CYTOREDUCTIVE MODEL USING BMT AND COSTIMULATION BLOCKADEANONE MARROW TRANSPLANTATION.
47. HLA matching and outcome of heart transplantation.
48. Serial Biopsies of Sex-Mismatched Liver Transplants Show No Evidence for Recipient-Derived Hepatocytes.
49. Modulation of Lymphocyte Apoptosis to Induce Mixed Chimerism and Tolerance without Myelosuppression.
50. Therapeutic Use of Regulatory T Cells for Tolerance Induction: Mechanisms and Specificity in a Murine Mixed Chimerism Model.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.